10-Q: Blue Biofuels Reports Q1 2025 Results, Focuses on CTS Technology and SAF Production

Sentiment:

Quarterly Report


Blue Biofuels, Inc. reports its financial results for the quarter ended March 31, 2025, highlighting ongoing development of its CTS technology and plans for sustainable aviation fuel (SAF) production.

Capital raiseThe company anticipates needing additional funds for G&A expenses and will seek project financing for a commercial ethanol to SAF facility in addition to funds needed to complete the commercialization of its CTS system.The company has raised $175,000 through the issuance of notes and $50,000 through the issuance of shares in 2025.The company previously raised $17,160,625 in shares and $2,245,916 through converted notes and $1,430,000 in debt or convertible notes since inception.
Better than expectedThe net loss decreased significantly from $946,872 in Q1 2024 to $243,833 in Q1 2025.

Summary

  • Blue Biofuels, Inc. reported its financial results for the first quarter of 2025.
  • The company is focused on developing its patented Cellulose-to-Sugar (CTS) process for biofuel production.
  • They are also pursuing the production of Sustainable Aviation Fuel (SAF) through a joint venture.
  • The company had no revenue for the three months ended March 31, 2025 and 2024.
  • General and administrative expenses increased to $338,098 in Q1 2025 from $295,982 in Q1 2024.
  • Research and development expenses decreased to $350,707 in Q1 2025 from $607,635 in Q1 2024.
  • The net loss for the quarter was $243,833, compared to a net loss of $946,872 for the same period in 2024.
  • As of March 31, 2025, the company had a cash balance of $7,583 and a stockholders deficit of $2,951,571.
  • The company is dependent on obtaining financing to meet its obligations and generate revenue.
  • The company issued 44,000 shares for the cashless exercise of options and 1,125,000 shares and warrants for the conversion of $50,000 in debt and $50,000 in cash since January 1, 2025.
  • The company received $75,000 from a board member in exchange for a note after April 1, 2025.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While the company is making progress in developing its technology and pursuing SAF production, it faces significant financial challenges, including a limited cash balance and accumulated losses. The decrease in net loss is a positive sign, but the company's dependence on additional financing raises concerns.

Positives

  • The net loss decreased significantly from $946,872 in Q1 2024 to $243,833 in Q1 2025.
  • The company recognized $440,970 in grant income from the DOE SBIR grant.
  • The company is actively pursuing the development of its CTS technology and SAF production.
  • Research and development expenses decreased to $350,707 in Q1 2025 from $607,635 in Q1 2024.

Negatives

  • The company has a limited cash balance of $7,583 as of March 31, 2025.
  • The company has a working capital deficit of $2,289,706 as of March 31, 2025.
  • The company has incurred accumulated losses of $57,499,594 since its inception.
  • The company has not generated any material revenues from its business.

Risks

  • The company's ability to continue as a going concern is dependent on obtaining financing and generating revenue.
  • The company faces competition in the ethanol industry.
  • The company's plan to produce SAF requires project financing and government permits.
  • The company's profitability depends on long-term purchase agreements with cellulosic feedstock suppliers.
  • The company may be unable to raise additional capital on acceptable terms.

Future Outlook

The company anticipates needing additional funds for G&A expenses and will seek project financing for a commercial ethanol to SAF facility in addition to funds needed to complete the commercialization of its CTS system.

Management Comments

  • Management believes that the Companys future success is dependent upon its ability to achieve profitable operations, generate cash from operating activities, and obtain additional financing.
  • The Company believes that its management and consultants have significant experience in the development of technologies from concept to commercialization.

Industry Context

The company operates in the competitive ethanol industry and is positioning itself to benefit from government incentives for cellulosic biofuels and sustainable aviation fuel.

Comparison to Industry Standards

  • The report mentions that the ethanol industry is competitive with over 200 ethanol plants in the United States, most of which use corn as feedstock.
  • Blue Biofuels aims to differentiate itself by using cellulosic feedstocks, which are non-food and have lower costs than corn.
  • The company also expects to benefit from higher incentives for cellulosic biofuels compared to corn ethanol, such as the D3 RIN credit.
  • The company is also pursuing the production of Sustainable Aviation Fuel (SAF), which is a growing area of interest in the biofuels industry.
  • The company has licensed the Vertimass Process which is a patented one step process that converts ethanol into sustainable aviation fuel (SAF) and other renewable biofuels including bio-gasoline.

Legal Proceedings

  • The Company is subject, from time to time, to litigation, claims and suits arising in the ordinary course of business.
  • As of the date of filing, there are no material claims or suits whose outcomes could have a material effect on the Companys financial statements.

Related Party Transactions

  • Short-term notes payable, convertible notes, and legacy liabilities issued to related parties are described in NOTE 6.
  • A board resolution was passed on February 13, 2020 that pledged the patents and pending patents to secure the back pay claims of Ben Slager, CEO, Anthony Santelli, CFO, and Charles Sills, Director.
  • During 2024, the board of directors approved an increase in salaries to two officers of the Company retroactive to August 1, 2023.
  • In June 2024, the board of directors approved a partial anti-dilution compensation for CEO Ben Slager, CFO Anthony Santelli, and Director Chris Kneppers to be paid in restricted stock units and options.
  • As of April 1, 2024, the board of directors approved ceasing accruing interest on back pay due to officers and on directors fees.
  • As of August 28, 2024, each Director that is not an Officer shall receive 3.5% in cash and 3.5% in warrants for any investor first introduced to the Company by the Director.

Stakeholder Impact

  • Shareholders are impacted by the company's financial performance and its ability to raise capital.
  • Employees are impacted by the company's ability to fund operations and pay salaries.
  • Customers and suppliers are impacted by the company's ability to commercialize its technology and produce biofuels.
  • Creditors are impacted by the company's ability to repay its debts.

Next Steps

  • The company plans to continue developing its CTS technology and optimizing its pilot plant.
  • The company intends to pursue project financing for a commercial ethanol to SAF facility.
  • The company plans to apply for RIN credits and Clean Fuel Production Credits as it brings its first plant into commercial operation.
  • The company plans to analyze the cost effectiveness of applying for LCFS credits in various states.
  • The company intends to grow with additional plants in the United States and explore international growth.

Key Dates

DateDescription
2012-03-28Blue Biofuels, Inc. was incorporated in Nevada as Alliance Media Group Holdings, Inc.
2013-12-01Blue Biofuels, Inc. focused on emerging technologies in renewable energy, biofuels, and lignin.
2018-10-22The Company voluntarily filed for Chapter 11 bankruptcy.
2019-09-18The Company exited Chapter 11 bankruptcy.
2019-10-25The bankruptcy case was closed.
2021-01-01CTS patent was awarded in the United States (U.S. Patent No. 10,994,255).
2022-01-01The Company partnered with K.R. Komarek to build its CTS machines.
2022-08-16Section 45Z of the Inflation Reduction Act passed.
2023-01-01The Company completed the build-out of a pilot plant based on a modified Komarek machine and optimized the core process.
2023-06-01The Company entered two long-term convertible notes with board member Edmund Burke with principal amounts of $25,000 and $15,000, respectively.
2023-11-01The Company entered two long-term convertible notes with board member Edmund Burke with principal amounts of $25,000 and $15,000, respectively.
2023-12-01The Company issued a convertible note to one individual for $50,000.
2024-01-01The Company formed a 50-50 joint venture partnership with Vertimass called VertiBlue Fuels, LLC.
2024-08-28Each Director that is not an Officer shall receive 3.5% in cash and 3.5% in warrants for any investor first introduced to the Company by the Director.
2024-09-01The Company was awarded a Small Business Innovation Research (SBIR) grant by the U.S. Department of Energy (DOE) in the amount of $ 1.15 million.
2025-01-01The convertible note issued in December 2023 was converted into 625,000 shares of the Company's common stock and 625,000 warrants.
2025-03-31End of the financial period for this report.
2025-04-01From April 1, 2025 to the date of this filing, the Company issued 500,000 shares and warrants for $ 50,000 to an unrelated party.
2025-04-01From April 1, 2025 to the date of this filing, the Company received $ 75,000 from a board member in exchange for a note.
2025-04-11Latest practicable date for number of shares outstanding.
2025-04-30Date of report filing.

Keywords

biofuels, CTS process, sustainable aviation fuel, SAF, cellulosic ethanol, renewable energy, Vertimass, grant income, SBIR, Department of Energy, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.